| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. | Ann Rheum Dis | 2012 | 1.17 |
| 2 | Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study. | Cancer Chemother Pharmacol | 2009 | 0.85 |
| 3 | Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer. | Invest New Drugs | 2008 | 0.83 |
| 4 | Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study. | Mod Rheumatol | 2014 | 0.80 |
| 5 | Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma. | Clin Drug Investig | 2005 | 0.78 |
| 6 | Short-term safety and tolerability of double-dose salmeterol/fluticasone propionate in adult asthmatic patients. | Clin Drug Investig | 2005 | 0.75 |